PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
10/31/2024 | 07/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 17.30% | 7.48% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 17.30% | 7.48% | |||
Cost of Revenue | 16.08% | 8.74% | |||
Gross Profit | 18.18% | 6.59% | |||
SG&A Expenses | 4.26% | -15.33% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 6.29% | -11.53% | |||
Operating Income | 1.88% | 21.79% | |||
Income Before Tax | 8.86% | 11.79% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 8.86% | 11.79% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 8.86% | 11.79% | |||
EBIT | 1.88% | 21.79% | |||
EBITDA | 1.83% | 23.05% | |||
EPS Basic | 8.82% | 11.69% | |||
Normalized Basic EPS | 2.56% | 18.75% | |||
EPS Diluted | 8.82% | 11.69% | |||
Normalized Diluted EPS | 2.56% | 18.75% | |||
Average Basic Shares Outstanding | 0.00% | 0.00% | |||
Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |